Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
EBIT MarginEBITDA MarginEBT MarginFCF MarginInterest Coverage RatioNet MarginOperating MarginReturn on SalesTimes Interest Earned

Kraig Biocraft Laboratories (KBLB) Return on Equity (2016 - 2022)

Kraig Biocraft Laboratories (KBLB) has disclosed Return on Equity for 9 consecutive years, with 1.07% as the latest value for Q3 2022.

  • Quarterly Return on Equity fell 39.0% to 1.07% in Q3 2022 from the year-ago period, while the trailing twelve-month figure was 1.07% through Sep 2022, down 39.0% year-over-year, with the annual reading at 0.3% for FY2018, 52.0% down from the prior year.
  • Return on Equity hit 1.07% in Q3 2022 for Kraig Biocraft Laboratories, down from 1.63% in the prior quarter.
  • In the past five years, Return on Equity ranged from a high of 1.73% in Q1 2022 to a low of 0.25% in Q3 2018.
  • Historically, Return on Equity has averaged 0.82% across 4 years, with a median of 0.59% in 2018.
  • Biggest five-year swings in Return on Equity: tumbled -110bps in 2018 and later skyrocketed 122bps in 2022.
  • Year by year, Return on Equity stood at 0.28% in 2018, then soared by 108bps to 0.58% in 2019, then skyrocketed by 149bps to 1.44% in 2021, then decreased by -25bps to 1.07% in 2022.
  • Business Quant data shows Return on Equity for KBLB at 1.07% in Q3 2022, 1.63% in Q2 2022, and 1.73% in Q1 2022.